Clinical utility of molecular and flow cytometric markers in chronic lymphocytic leukaemia
Melanie Sulda(Flinders Medical Centre), Peter J. Macardle(Flinders Medical Centre), Bryone J. Kuss(Flinders Medical Centre), Sheree Bailey(University of South Australia), Roger K. Hall
Cited by 6
Related Papers
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
|The Lancet|2021|456
CD molecules 2006 — Human cell differentiation molecules
|Journal of Immunological Methods|2006|164
Antibody‐Functionalized Porous Silicon Nanoparticles for Vectorization of Hydrophobic Drugs
|Advanced Healthcare Materials|2012|130
Preparation and characterization of a chimeric CD 19 monoclonal antibody
|Immunology and Cell Biology|1991|103